"Quantifying the number of U.S. adults eligible for semaglutide may guide future policies for this high-cost therapy and ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy ... He is concerned about the financial costs and health risks potentially posed by these drugs. There is ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...